P. Lal

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Scott A. Prentice, Tom Michael Mitchell, Deborah A. Gilliam, 2017 .

Outcome of late-onset hospital-acquired pneumonia related to causative organism.

Richard H. McClure, T. Jones, P. Lal, 2009, The Journal of hospital infection.

Asthma and vasculitis: controversial association with leukotriene antagonists.

L. Bielory, P. Lal, M. Gewirtz, 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Molecular typing of Salmonella enterica serotype Worthington isolates from infantile diarrhoea.

P. Lal, Shamweel Ahmad, M. Deb, 2006, The Indian journal of medical research.

Unusual case of Candida Krusei implicated in Ludwig’s angina and deep neck necrotising infection

P. Lal, F. Khalid, M. Aljefri, 2022, Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology.

Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT.

A. Walker, G. Barlow, M. Soares, 2018, Health technology assessment.

Yersinia enterocolitica: a Rare Cause of Infective Endocarditis and Mycotic Aneurysm

F. Torella, P. Lal, J. Anson, 2014 .

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Scott A. Prentice, Tom Michael Mitchell, Deborah A. Gilliam, 2018, Lancet.